Abstract
The market for respiratory disorder treatments is continuing to experience
rapid expansion as healthcare payors increasingly acknowledge the high
treatment costs associated with chronic indications. A shift in developmental
focus has become the driving force for market transformation, with research
efforts now targeting the causative disease pathway in an effort to prevent
symptom presentation and pathological decline. In the short term, a number of
impending product launches will satisfy unmet demand within high-value market
niches by addressing issues of patient compliance and targeting patients at
the more severe end of the disease spectrum. ‘Innovations and Pipelines
for Respiratory Disorders' is a new report published by Business Insights that
examines the future of the respiratory disorders market and explores the
dynamics and drivers for current and emerging treatments.
This report assesses leading mechanisms of action in drug development
pipelines based upon clinical/preclinical results, potential market
positioning and sales success in addition to identifying associated investment
opportunities. The major trends and issues affecting new product development
are highlighted and the future potential of leading innovations is evaluated.
This report also identifies major areas of unmet market need and provides a
detailed assessment of the currently marketed portfolios and developmental
products of key companies within the sector. Explore the latest trends and
innovations in respiratory treatments, assess the performances of currently
marketed medications and evaluate the potential of leading pipeline candidates
with this report.
View Cart
